Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Hepatitis C (approved 1986)
Alzheimer Disease (Phase 2)
Behcet Syndrome (Phase 3)
Birdshot Chorioretinopathy (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma, Renal Cell (Phase 2)
Glomerulonephritis, Membranous (Phase 2)
Healthy Volunteers (Phase 1)
Hemangiosarcoma (Phase 1)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis D, Chronic (Phase 2)
Hepatitis Delta Virus (Phase 3)
HIV Infections (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Liver (Phase 2)
Lymphoma (Phase 3)
Lymphoma, Follicular (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Macular Edema (Phase 2)
Melanoma (Phase 3)
Memory Disorders (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 2)
Panuveitis (Phase 3)
Primary Myelofibrosis (Phase 1)
Psoriasis (Phase 1)
Retinal Vasculitis (Phase 3)
Uveitis (Phase 3)
Uveitis, Posterior (Phase 3)
Vision Disorders (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue